The UNC MFM division would like to take this opportunity to keep you informed of the current details on how to prescribe progesterone to your patients.

FDA has concluded that the risk of serious adverse events outweighs any potential benefit to pregnant women receiving prolonged treatment with terbutaline injection (beyond 48-72 hours), or acute or prolonged treatment with oral terbutaline.

Providers may have noticed that certain labs in the US have started testing for syphilis using treponemal tests (EIA or TP-PA) as first line tests. This has created confusion in how to interpret the results.